Oak Street Health Inc

Oak Street Health Inc

  • Price (EUR)33.00
  • Today's Change0.20 / 0.61%
  • Shares traded0.00
  • 1 Year change+39.83%
  • Beta--
Data delayed at least 15 minutes, as of Mar 27 2023 07:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Oak Street Health, Inc. operates a network of primary care centers for adults on Medicare. The Company operates primary care centers within the United States serving Medicare beneficiaries. The Company, through its centers and management services organization, combines a care model with patient experience. The Company invests resources into primary care to prevent unnecessary acute events and manage chronic illnesses. It engages Medicare-eligible patients using a community outreach approach. Once patients are engaged, it integrates population health analytics, social support services, and primary care into the care model. It offers a technology platform in New York providing access to specialist expertise through RubiconMD Holdings, Inc. (Rubicon). It operates through its direct and indirect subsidiaries, primarily, Oak Street Health MSO, LLC (OSH MSO). OSH MSO operates as a management services organization. The Company operates approximately 140 centers across 20 states.

  • Revenue in USD (TTM)2.16bn
  • Net income in USD-509.30m
  • Incorporated2019
  • Employees3.80k
  • Location
    Oak Street Health Inc30 W. Monroe St., Ste. 1200CHICAGO 60603United StatesUSA
  • Phone+1 (312) 773-3374
  • Fax+1 (302) 655-5049
  • Websitehttps://www.oakstreethealth.com
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.